AI, or artificial intelligence, has taken root in biotech. In this article, a contributor exploresits newfound niches in the industry.
Artificial intelligence (AI) and machine learning (ML) have become ubiquitous in tech startups, fueled largely by the increasing availability and amount of data and cheaper, more powerful computers. Now, if you are a new tech startup, ML or AI capabilities representyour minimum ticket to enter the industry. Over the past few years, AI and ML have started to peek their heads into the realm of biotech, due to an analogous transformation of biotech data.
We are beginning to see partnerships form between Big Pharma and biotech startups that employ AI and ML for drug discovery and other purposes. Positive results have already come out of joint projects, notably the delay in the onset of motor neuron disease in anefficacy study conducted by SITraN on a drug candidate proposed by BenevolentBIO.
With these results in mind, we must ask ourselves the question, what is the role of AI and ML now and also in the future of biotech?
Diagnostic assays today are usually developed once and only updated when there is a significant paradigm shift. Because of this, there are missed opportunities to improve the assay when the true results of previous diagnoses become known. However, ML techniques can immediately use the true result to improve the diagnostic test. This means that the more diagnostic tests that are run, the more accurate the test can become.
Currently, the most obvious implementation of ML techniques for diagnostics lies in genetic analysis. Sophia Genetics, the Swiss startup founded in 2011, exemplifies the state of the art. They intake a biopsy or blood sample from the patient, process the sample, and then analyze the data with their powerful analytical AI algorithms.
In Sophia Genetics case, the data analysis takes a few days withits platform, rather than several months like the current standard. While speed is clearly a benefit, the long-term advantage is that the machine learning algorithm thats behind the AI analysis enables the diagnostic process to become smarter with each iteration.
Besides genetic analysis, ML techniques can be used in any diagnostic that can be digitized, allowing the algorithm to determine the correct features to embed into its final decision-making process. DNAlytics demonstrates another use of ML in diagnostics, using the advanced computations to help diagnose rheumatoid arthritis.
Tedious tasks done in the lab such as designing constructs for gene editing or data analysis are slowly being handed over to AI programs as well, as a sort ofsecretarial work. Desktop Genetics has created a novel platform to design gene editing constructs using CRISPR that works through AI. Their gene editing platform follows the entire process, from selecting proper sgRNA molecules to analyzing the data of the experiment.
The power of AI allows them to more quickly and effectively constructCRISPR libraries that may be needed for a single experiment or an entire lab. Especially for people who do not have much experience working with CRISPR, this platform is valuable to not only expedite the processfrom designing to conducting an experiment but also to ensure that the guides are as effective as they can be, improving the efficacy ofgene editing.
For scientists who want quicker and/or easier data analysis, there are startups focused on using AI to look at many types of data. H2O.ai is an open-source platform on which people can analyze data using thousands of different statistical analysis models. While H2O.ai is industry-agnostic, there are a few startups focused specifically on healthcare and biotech data, alleviating the burden of data analysis from healthcare providers.
Increasingly more data is being generated, but not all of this data can be used, much less appropriately, at the moment. These startups are aiming to reduce the bottleneck at data analysis to take advantage of the rich datasets that exist.
Arguably, the most exciting advances in biotech using AI and ML have been in drug discovery. Current drug discovery economics are unsustainable, with costs now averaging over $2.5Band 12 years of trials for a single drug. The low-hanging fruit have already been picked, yet new approaches have not risen to reach the higher hanging ones.
However, AI and ML hope to be the solution that Big Pharma has been looking for. The computing technologies promise to make drug discovery cheaper and quicker, effectively making the time needed for lead discovery a small fraction of what it is today. Partnerships are already forming between young startups and pharma giants, and we should expect more to come at an increasing rate.
Several approaches exist for startups to make these advances happen. Some startups are focused on leveraging the increasing amount of genetic data and cheap sequencing to approach drug discovery from a genetics standpoint. Others are employing computer vision to analyze images of cells that have been treated with drug compounds, which eliminates the need for scores of PhDs to painstakingly peer into a microscope and screen for compounds of interest.
A few companies are taking a structure-based approach to drug discovery, using ML to find small molecules that could provide therapeutic benefits based on known target structures. Lastly, startups like BenevolentBIO use AI to pore over the vast, existing scientific data. With those results, they can make use of previously conducted studies to better inform future experiments and clue researchers into possible missteps in previous trials or even better designations for drugs.
With AI and ML seeping into more and more parts of biotech, what will the future bring? Lab assistant startups and diagnostics are trying to make healthcare providers and scientists more effective at their job, and I foresee the incorporation of tech making the pie bigger for almost everyone in these spaces.
For drug discovery, there seems to be a less symbiotic relationship at play with their customers. The startups act as Drug-Candidates-as-a-Service (DCaaS) companies, selling their findings to those who have the capital, both financial and human, to push the candidates further down the research pipeline.
Yet, aside from IBMs Watson initiative, large companies seem content to outsource this lead discovery step in R&D. Are they short-sighted? What happens to current behemoths when these small startups creep further into the R&D pipeline, conducting their own clinical trials and eventually selling the drugs they find themselves?
If we assume that the infusion of AI and ML into biotech will only increase, there seems to be only two outcomes: large companies with cash to spare will start acquiring these startups early and embedding the computational techniques into their current R&D structure, or current market leaders will slowly lose their grip on drug development to tech-enabled biotechs and become content producing generic drugs, at best.
With all of the good aspects of AI in biotech, there are a few challenges that could put a damper on progress. Most notably, the large volume of data is often stored in disparate or incompatible mediums, making it difficult to consolidate results and draw upon the entire wealth of data. Furthermore, data privacy is also a concern, particularly for companies using cloud computing to analyze patient-derived data, but at least in the US trailblazers have already jumped this hurdle.
Overall, AI and ML are coming into biotech and are here to stay. What will exactly happen is still up for debate, and AI biotech companies are still being formed, with good reason. The future of biotech is being written at this moment. The question is: who is writing it and what are they writing?
Michael Snyder. MBA Candidate at the Graduate School of Business at Stanford. Formerly a bioengineering researcher at EPFL and Boston University.
Images from Dmitry Rybin, Phonlamai Photo, Elnur, agsandrew, Bas Nastassia / shutterstock.com
See the article here:
The Robots are Coming: Is AI the Future of Biotech? - Labiotech.eu (blog)
- Classic reasoning systems like Loom and PowerLoom vs. more modern systems based on probalistic networks - November 8th, 2009 [November 8th, 2009]
- Using Amazon's cloud service for computationally expensive calculations - November 8th, 2009 [November 8th, 2009]
- Software environments for working on AI projects - November 8th, 2009 [November 8th, 2009]
- New version of my NLP toolkit - November 8th, 2009 [November 8th, 2009]
- Semantic Web: through the back door with HTML and CSS - November 8th, 2009 [November 8th, 2009]
- Java FastTag part of speech tagger is now released under the LGPL - November 8th, 2009 [November 8th, 2009]
- Defining AI and Knowledge Engineering - November 8th, 2009 [November 8th, 2009]
- Great Overview of Knowledge Representation - November 8th, 2009 [November 8th, 2009]
- Something like Google page rank for semantic web URIs - November 8th, 2009 [November 8th, 2009]
- My experiences writing AI software for vehicle control in games and virtual reality systems - November 8th, 2009 [November 8th, 2009]
- The URL for this blog has changed - November 8th, 2009 [November 8th, 2009]
- I have a new page on Knowledge Management - November 8th, 2009 [November 8th, 2009]
- N-GRAM analysis using Ruby - November 8th, 2009 [November 8th, 2009]
- Good video: Knowledge Representation and the Semantic Web - November 8th, 2009 [November 8th, 2009]
- Using the PowerLoom reasoning system with JRuby - November 8th, 2009 [November 8th, 2009]
- Machines Like Us - November 8th, 2009 [November 8th, 2009]
- RapidMiner machine learning, data mining, and visualization tool - November 8th, 2009 [November 8th, 2009]
- texai.org - November 8th, 2009 [November 8th, 2009]
- NLTK: The Natural Language Toolkit - November 8th, 2009 [November 8th, 2009]
- My OpenCalais Ruby client library - November 8th, 2009 [November 8th, 2009]
- Ruby API for accessing Freebase/Metaweb structured data - November 8th, 2009 [November 8th, 2009]
- Protégé OWL Ontology Editor - November 8th, 2009 [November 8th, 2009]
- New version of Numenta software is available - November 8th, 2009 [November 8th, 2009]
- Very nice: Elsevier IJCAI AI Journal articles now available for free as PDFs - November 8th, 2009 [November 8th, 2009]
- Verison 2.0 of OpenCyc is available - November 8th, 2009 [November 8th, 2009]
- What’s Your Biggest Question about Artificial Intelligence? [Article] - November 8th, 2009 [November 8th, 2009]
- Minimax Search [Knowledge] - November 8th, 2009 [November 8th, 2009]
- Decision Tree [Knowledge] - November 8th, 2009 [November 8th, 2009]
- More AI Content & Format Preference Poll [Article] - November 8th, 2009 [November 8th, 2009]
- New Planners Solve Rescue Missions [News] - November 8th, 2009 [November 8th, 2009]
- Neural Network Learns to Bluff at Poker [News] - November 8th, 2009 [November 8th, 2009]
- Pushing the Limits of Game AI Technology [News] - November 8th, 2009 [November 8th, 2009]
- Mining Data for the Netflix Prize [News] - November 8th, 2009 [November 8th, 2009]
- Interview with Peter Denning on the Principles of Computing [News] - November 8th, 2009 [November 8th, 2009]
- Decision Making for Medical Support [News] - November 8th, 2009 [November 8th, 2009]
- Neural Network Creates Music CD [News] - November 8th, 2009 [November 8th, 2009]
- jKilavuz - a guide in the polygon soup [News] - November 8th, 2009 [November 8th, 2009]
- Artificial General Intelligence: Now Is the Time [News] - November 8th, 2009 [November 8th, 2009]
- Apply AI 2007 Roundtable Report [News] - November 8th, 2009 [November 8th, 2009]
- What Would You do With 80 Cores? [News] - November 8th, 2009 [November 8th, 2009]
- Software Finds Learning Language Child's Play [News] - November 8th, 2009 [November 8th, 2009]
- Artificial Intelligence in Games [Article] - November 8th, 2009 [November 8th, 2009]
- Artificial Intelligence Resources - November 8th, 2009 [November 8th, 2009]
- Alan Turing: Mathematical Biologist? - April 25th, 2012 [April 25th, 2012]
- BBC Horizon: The Hunt for AI ( Artificial Intelligence ) - Video - April 30th, 2012 [April 30th, 2012]
- Can computers have true artificial intelligence" Masonic handshake" 3rd-April-2012 - Video - April 30th, 2012 [April 30th, 2012]
- Kevin B. Korb - Interview - Artificial Intelligence and the Singularity p3 - Video - April 30th, 2012 [April 30th, 2012]
- Artificial Intelligence - 6 Month Anniversary - Video - April 30th, 2012 [April 30th, 2012]
- Science Breakthroughs - April 30th, 2012 [April 30th, 2012]
- Hitman: Blood Money - Part 49 - Stupid Artificial Intelligence! - Video - April 30th, 2012 [April 30th, 2012]
- Research Members Turned Off By HAARP Artificial Intelligence - Video - April 30th, 2012 [April 30th, 2012]
- Artificial Intelligence Lecture No. 5 - Video - April 30th, 2012 [April 30th, 2012]
- The Artificial Intelligence Laboratory, 2012 - Video - April 30th, 2012 [April 30th, 2012]
- Charlie Rose - Artificial Intelligence - Video - April 30th, 2012 [April 30th, 2012]
- Expert on artificial intelligence to speak at EPIIC Nights dinner - May 4th, 2012 [May 4th, 2012]
- Filipino software engineers complete and best thousands on Stanford’s Artificial Intelligence Course - May 4th, 2012 [May 4th, 2012]
- Vodafone xone™ Hackathon Challenges Developers and Entrepreneurs to Build a New Generation of Artificial Intelligence ... - May 4th, 2012 [May 4th, 2012]
- Rocket Fuel Packages Up CPG Booster - May 4th, 2012 [May 4th, 2012]
- 2 Filipinos finishes among top in Stanford’s Artificial Intelligence course - May 5th, 2012 [May 5th, 2012]
- Why Your Brain Isn't A Computer - May 5th, 2012 [May 5th, 2012]
- 2 Pinoy software engineers complete Stanford's AI course - May 7th, 2012 [May 7th, 2012]
- Percipio Media, LLC Proudly Accepts Partnership With MIT's Prestigious Computer Science And Artificial Intelligence ... - May 10th, 2012 [May 10th, 2012]
- Google Driverless Car Ok'd by Nevada - May 10th, 2012 [May 10th, 2012]
- Moving Beyond the Marketing Funnel: Rocket Fuel and Forrester Research Announce Free Webinar - May 10th, 2012 [May 10th, 2012]
- Rocket Fuel Wins 2012 San Francisco Business Times Tech & Innovation Award - May 13th, 2012 [May 13th, 2012]
- Internet Week 2012: Rocket Fuel to Speak at OMMA RTB - May 16th, 2012 [May 16th, 2012]
- How to Get the Most Out of Your Facebook Ads -- Rocket Fuel's VP of Products, Eshwar Belani, to Lead MarketingProfs ... - May 16th, 2012 [May 16th, 2012]
- The Digital Disruptor To Banking Has Just Gone International - May 16th, 2012 [May 16th, 2012]
- Moving Beyond the Marketing Funnel: Rocket Fuel Announce Free Webinar Featuring an Independent Research Firm - May 23rd, 2012 [May 23rd, 2012]
- MASA Showcases Latest Version of MASA SWORD for Homeland Security Markets - May 23rd, 2012 [May 23rd, 2012]
- Bluesky Launches Drones for Aerial Surveying - May 23rd, 2012 [May 23rd, 2012]
- Artificial Intelligence: What happened to the hunt for thinking machines? - May 25th, 2012 [May 25th, 2012]
- Bubble Robots Move Using Lasers [VIDEO] - May 25th, 2012 [May 25th, 2012]
- UHV assistant professors receive $10,000 summer research grants - May 27th, 2012 [May 27th, 2012]
- Artificial intelligence: science fiction or simply science? - May 28th, 2012 [May 28th, 2012]
- Exetel taps artificial intelligence - May 29th, 2012 [May 29th, 2012]
- Software offers brain on the rain - May 29th, 2012 [May 29th, 2012]
- New Dean of Science has high hopes for his faculty - May 30th, 2012 [May 30th, 2012]
- Cognitive Code Announces "Silvia For Android" App - May 31st, 2012 [May 31st, 2012]
- A Rat is Smarter Than Google - June 5th, 2012 [June 5th, 2012]